PortViewPortView
ISUL logo

GraniteShares 2x Long ISRG Daily (ISUL) ETF Holdings & Analysis

ETFOther

$14.41+5.57%
1-year price historyRange $11.44 – $41.14
52-week range$14.41
$11.06$42.60

What ISUL does

This exchange-traded fund (ETF) aims to deliver, prior to fees and expenses, double (200%) the daily percentage movement of Intuitive Surgical, Inc. (NASDAQ: ISRG) common stock. However, achieving this exact daily objective is not guaranteed. It is crucial to understand that this fund is not designed to provide twice the cumulative return of ISRG for periods extending beyond a single day, and investors should not anticipate such long-term performance.

Fund profile

Category
Other
AUM
$10.09M
Holdings
2
52-week high
$42.60
52-week low
$11.06

Top holdings

Top 2100%
HoldingWeight
ISRG66.68%
US Dollars33.32%

Geographic allocation

Other33.32%
United States66.68%

PortView Portfolio Insights

PortView analyzes how ISUL fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ISUL in PortView →

Related securities

Related stocks

Frequently asked questions

What does ISUL track?
ISUL is the GraniteShares 2x Long ISRG Daily ETF, a Other ETF.
What is the expense ratio of ISUL?
Expense ratio data for ISUL is shown on the page when available from our data provider.
What are the largest holdings in ISUL?
Top holdings include ISRG, US Dollars.
How can PortView analyze ISUL overlap with other ETFs?
PortView computes the holdings overlap between ISUL and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.